One Year Follow-Up of Children and Adolescents With Chronic Immune Thrombocytopenic Purpura (ITP) Treated With Rituximab

BACKGROUND: We previously showed in a prospective study that rituximab appears to be effective in some children and adolescents with severe chronic immune thrombocytopenia. Eleven of 36 patients achieved and maintained platelet counts over 50,000/mm(3) within the first 12 weeks. These patients were...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Blood Cancer
Autors principals: Mueller, Brigitta U., Bennett, Carolyn M., Feldman, Henry A., Bussel, James B., Abshire, Thomas C., Moore, Theodore B., Sawaf, Hadi, Loh, Mignon L., Rogers, Zora R., Glader, Bertil E., McCarthy, Maggie C., Mahoney, Donald H., Olson, Thomas A., Feig, Stephen A., Lorenzana, Adonis N., Mentzer, William C., Buchanan, George R., Neufeld, Ellis J.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5752113/
https://ncbi.nlm.nih.gov/pubmed/18937333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21757
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars